Adam D. Cutler's Net Worth
$244 Thousand
Who is Adam D. Cutler?
Adam D. Cutler does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include NAVIDEA BIOPHARMACEUTICALS, INC., InMed Pharmaceuticals Inc., Molecular Templates, Inc., and Mural Oncology plc.
SEC CIK
Adam D. Cutler's CIK is 0001722673
Past Insider Trading and Trends
2020 was Adam D. Cutler's most active year for acquiring shares with 2 total transactions. Adam D. Cutler's most active month to acquire stocks was the month of November. 2022 was Adam D. Cutler's most active year for disposing of shares, totalling 3 transactions. Adam D. Cutler's most active month to dispose stocks was the month of December. 2017 saw Adam D. Cutler paying a total of $0.00 for 225,000 shares, this is the most they've acquired in one year. In 2022 Adam D. Cutler cashed out on 30,303 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Snapshot price: $0.0251
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
InMed Pharmaceuticals Inc. (INM) Snapshot price: $0.2718
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Molecular Templates, Inc. (MTEM) Snapshot price: $1.53
See remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Mural Oncology plc (MURA) Snapshot price: $3.1
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -9.41% | -7.42K |
$3.41 | -$25,305.61 | 71.44K |
Oct 31
| |||
Form 4
|
∞
| 78.86K |
—
|
—
| 78.86K |
Dec 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |